Association Between Inflammatory Markers and Cognitive Impairment in Patients with Asymptomatic Carotid Stenosis

1 Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, Van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet. 1997;349(9046):151-4. https://doi.org/10.1016/S0140-6736(96)09328-2 PMid:9111537 Search in Google Scholar

2 Johnston SC, O’Meara ES, Manolio TA, Lefkowitz D, O’Leary DH, Goldstein S, et al. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Internal Med. 2004;140(4):237-47. https://doi.org/10.7326/0003-4819-140-4-200402170-0000 PMid:14970146 Search in Google Scholar

3 Mathiesen EB, Waterloo K, Joakimsen O, Bakke SJ, Jacobsen EA, Bonaa KH. Reduced neuropsychological test performance in asymptomatic carotid stenosis: The tromso study. Neurology. 2004;62(5):695-701. https://doi.org/10.1212/01.wnl.0000113759.80877.1f PMid:15007116 Search in Google Scholar

4 Pettigrew LC, Thomas N, Howard VJ, Veltkamp R, Toole JF. Low mini-mental status predicts mortality in asymptomatic carotid arterial stenosis. Asymptomatic carotid atherosclerosis study investigators. Neurology. 2000;55(1):30-4. https://doi.org/10.1212/wnl.55.1.30 PMid:10891899 Search in Google Scholar

5 Sabeti S, Exner M, Mlekusch W, Amighi J, Quehenberger P, Rumpold H, et al. Prognostic impact of fibrinogen in carotid atherosclerosis: Nonspecific indicator of inflammation or independent predictor of disease progression? Stroke. 2005;36(7):1400-4. https://doi.org/10.1161/01.STR.0000169931.96670.fc PMid:15933258 Search in Google Scholar

6 Elkind M, Cheng J, Albala B, Paik M, Sacco R. Elevated white blood cell count and carotid plaque thickness. The Northern Manhattan stroke study. Stroke. 2001;32(4):842-9. https://doi.org/10.1161/01.str.32.4.842 PMid:11283380 Search in Google Scholar

7 Assayag EB, Bova I, Kesler A, Berliner S, Shapira I, Bornstein NM. Erythrocyte aggregation as an early biomarker in patients with asymptomatic carotid stenosis. Dis Markers. 2008;24(1):33-9. https://doi.org/10.1155/2008/184647 PMid:18057534 Search in Google Scholar

8 Garcia BA, Ruiz C, Chacon P, Sabin JA, Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: Risk marker for unstable carotid plaque. J Vasc Surg. 2003;38(5):1018-24. https://doi.org/10.5114/aoms.2013.34533 PMid:14603210 Search in Google Scholar

9 Kablak-Ziembicka A, Przewlocki T, Sokołowski A, Tracz W, Podolec P. Carotid intima-media thickness, hs-CRP and TNF-α are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis. 2011;214(1):185-90. https://doi.org/10.1016/j.atherosclerosis.2010.10.017 PMid:21067752 Search in Google Scholar

10 Bond MG, Barnes RW, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B, The ARIC Study Group. High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities study (ARIC). J Neuroimag 1991;1:68-73. PMid:10149810 Search in Google Scholar

11 Larner AJ, Mitchell AJ. A meta-analysis of the accuracy of the Addenbrooke’s cognitive examination (ACE) and the Addenbrooke’s cognitive examination-revised (ACE-R) in the detection of dementia. Int Psychogeriatr. 2014;26(4):555-63. https://doi.org/10.1017/S1041610213002329 PMid:24423470 Search in Google Scholar

12 Kwah LK, Diong J. National institutes of health stroke scale (NIHSS). J Physiother. 2014;60(1):61. https://doi.org/10.1016/j.jphys.2013.12.012 PMid:24856948 Search in Google Scholar

13 Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340(2):115-26. https://doi.org/10.1056/NEJM199901143400207 PMid: 9887164 Search in Google Scholar

14 Pelisek J, Rudelius M, Zepper P, Poppert H, Reeps C, Schuster T, et al. Multiple biological predictors for vulnerable carotid lesions. Cerebrovasc Dis. 2009;28(6):601-10. https://doi.org/10.1159/000247605 PMid:19844101 Search in Google Scholar

15 Nishida H, Horio T, Suzuki Y, Iwashima Y, Tokudome T, Yoshihara F, et al. Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: Comparison with C-reactive protein. Cytokine. 2011;53(3):342-6. https://doi.org/10.1016/j.cyto.2010.12.005 PMid:21190868 Search in Google Scholar

16 Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res. 1999;85(8):e17-24. https://doi.org/10.1161/01.res.85.8.e17 PMid:10521249 Search in Google Scholar

17 Koutouzis M, Rallidis LS, Peros G, Nomikos A, Tzavara V, Barbatis C, et al. Serum interleukin-6 is elevated in symptomatic carotid bifurcation disease. Acta Neurol Scand. 2009;119(2):119-25. https://doi.org/10.1111/j.1600-0404.2008.01068.x PMid:18638042 Search in Google Scholar

18 Zhang L, Pappel K, Sivashanmugam P, Orman ES, Brian L, Exum ST, et al. Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(5):1087-94. https://doi.org/10.1161/ATVBAHA.0000261548.49790.63 PMid:17442899 Search in Google Scholar

19 Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscl Thromb Vasc Biol. 1999;19(10):2364-7. https://doi.org/10.1161/01.ATV.19.10.2364 PMid:10521365 Search in Google Scholar

20 Elkind MS, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H, et al. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke. 2002;33(1):31-7. https://doi.org/10.1161/hs0102.100531 PMid:11779885 Search in Google Scholar

21 Kyriakidis K, Antoniadis P, Choksy S, Papi RM. Comparative study of protein expression levels of five plaque biomarkers and relation with carotid plaque type classification in patients after carotid endarterectomy. Int J Vasc Med. 2018;2018:4305781. https://doi.org/10.1155/2018/4305781 PMid:30581625 Search in Google Scholar

22 Pearson TA, Mensah GA, Alexander WR, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cerebrovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from centers for disease control and prevention and the American heart association. Circulation. 2003;107(3):499-511. https://doi.org/10.1161/01.cir.0000052939.59093.45 PMid:12551878 Search in Google Scholar

23 Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin. 2003;21(3):315-25. https://doi.org/10.1016/s0733-8651(03)00079-1. PMID: 14621448. Search in Google Scholar

24 Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the predication of cardiovascular disease in women. N Engl J Med. 2000;342(12):836-43. https://doi.org/10.1056/NEJM200003233421202 PMid:10733371 Search in Google Scholar

25 Bruno D, Vignaga SS. Addenbrooke’s cognitive examination III in the diagnosis of dementia: A critical review. Neuropsychiatr Dis Treat. 2019;15:441-7. https://doi.org/10.2147/NDT.S151253 PMid:30858702 Search in Google Scholar

26 Panegyres PK, Berry R, Burchell J. Early dementia screening. Diagnostics (Basel). 2016;6(1):6. https://doi.org/10.3390/diagnostics6010006 PMid:26838803 Search in Google Scholar

27 Fiedorova D, Krulova P, Ressner P, Jaremova V, Slonkova J, Bar M, Skoloudik D, et al. Addenbrooke’s cognitive examination in nondemented patients after stroke. Neuropsychiatry. 2018;8(2):505-12. Search in Google Scholar

28 Lees RA, Hendry Ba K, Broomfield N, Stott D, Larner AJ, Quinn TJ. Cognitive assessment in stroke: Feasibility and test properties using differing approaches to scoring of incomplete items. Int J Geriatr Psychiatry. 2017;32(10):1072-8. https://doi.org/10.1002/gps.4568 PMid:27526678 Search in Google Scholar

29 Engelter ST, Gostynski M, Papa S, Frei M, Born C, Ajdacic-Gross V, et al. Epidemiology of aphasia attributable to first ischemic stroke: Incidence, severity, fluency, etiology, and thrombolysis. Stroke. 2006;37(6):1379-84. https://doi.org/10.1161/01.STR.0000221815.64093.8c PMid:16690899 Search in Google Scholar

30 Lal BK, Dux MC, Sikdar S, Goldstein C, Khan AA, Yokemick J, et al. Asymptomatic carotid stenosis is associated with cognitive impairment. J Vasc Surg. 2017;66(4):1083-92. https://doi.org/10.1016/j.jvs.2017.04.038 PMid:28712815 Search in Google Scholar

31 Rostamian S, Mahinrad S, Stijnen T, Sabayan B, De Craen AJ. Cognitive impairment and risk of stroke: A systematic review аnd meta-analysis of prospective cohort studies. Stroke. 2014;45(5):1342-8. https://doi.org/10.1161/STROKEAHA.114.004658 PMid:24676778 Search in Google Scholar

32 Arntzen KA, Schirmer H, Johnsen SH, Wilsgaard T, Mathiesen EB. Carotid atherosclerosis predicts lower cognitive test results: A 7-year follow-up study of 4,371 stroke-free subjects. The Tromsø study Cerebrovasc Dis. 2012;33(3):159-65. https://doi.org/10.1159/000334182 PMid:22222422 Search in Google Scholar

33 Romero JR, Beiser A, Seshadri S, Benjamin EJ, Polak JF, Vasan RS, et al. Carotid artery atherosclerosis, MRI indices of brain ischemia, aging and cognitive impairment: The Framingham study. Stroke. 2009;40(5):1590-6. https://doi.org/10.1161/strokeaha.108.535245 PMid:19265054 Search in Google Scholar

34 Martinić-Popović I, Lovrenčić-Huzjan A, Demarin V. Advanced asymptomatic carotid disease and cognitive impairment: An understated link? Stroke Res Treat. 2012;2012:981416. https://doi.org/10.1155/2012/981416 PMid:22577604 Search in Google Scholar